From: Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome
Response to anti-EGFR therapy
CR
PR
SD
PD
P**
Skin toxicity grade*
Grade 1
0
3
7
5
Grade 2
4
11
2
Grade 3
1
12
0.005